Gilead Raday
Geschäftsführer bei REDHILL BIOPHARMA LTD.
Vermögen: 101 853 $ am 30.04.2024
Aktive Positionen von Gilead Raday
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
REDHILL BIOPHARMA LTD. | Geschäftsführer | 01.04.2016 | - |
Corporate Officer/Principal | 10.11.2010 | 01.03.2016 |
Karriereverlauf von Gilead Raday
Ehemalige bekannte Positionen von Gilead Raday
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Sepal Pharma Plc
Sepal Pharma Plc Pharmaceuticals: MajorHealth Technology Sepal Pharma Plc is a British company that manufactures pharmaceutical preparations. | Vorstandsvorsitzender | 01.01.2010 | 01.10.2010 |
Corporate Officer/Principal | 01.01.2009 | 01.12.2009 | |
Charles Street Securities Europe LLP
Charles Street Securities Europe LLP Investment ManagersFinance Charles Street Securities Europe LLP (Charles Street) is a private equity firm founded in 1984. The firm is headquartered in the London, United Kingdom. | Private Equity Investor | 01.01.2004 | 01.01.2008 |
Vaccine Research International Plc
Vaccine Research International Plc Miscellaneous Commercial ServicesCommercial Services Vaccine Research International Plc is a British company that focuses on conducting clinical trials to evaluate the effectiveness of vaccine SA75 in preventing staphylococcal infections in hospital patients and the wider community. | Direktor/Vorstandsmitglied | - | - |
Vidac Pharma Ltd.
Vidac Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vidac Pharma Ltd. manufactures pharmaceutical products. It is a clinical stage biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases. The company was founded in 2011 by Max Herzberg is headquartered in Jerusalem, Israel. | Direktor/Vorstandsmitglied | - | - |
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 16.06.2005 | - |
Independent Dir/Board Member | 25.02.2013 | - | |
TK-Signal Ltd.
TK-Signal Ltd. Medical SpecialtiesHealth Technology TK-Signal Ltd. develops therapies for hematological cancer applications. Its product TKS040, which manage and trace focused drug therapy for cancer patients. The firm also develops various radiopharmaceutical molecular imaging tracers, specific molecular radiotherapy agents, and radioactive biomarkers to diagnose and monitor cancerous tumors. TK-Signal was founded in 2001 by Eyal Mishani and Alexander Levitzki and is headquartered in Jerusalem, Israel. | Direktor/Vorstandsmitglied | 18.02.2011 | - |
Ausbildung von Gilead Raday
University of Cambridge | Graduate Degree |
The Hebrew University of Jerusalem | Graduate Degree |
Statistik
International
Vereinigtes Königreich | 6 |
Israel | 5 |
Operativ
Director/Board Member | 4 |
Graduate Degree | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
REDHILL BIOPHARMA LTD. | Health Technology |
Private Unternehmen | 6 |
---|---|
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Charles Street Securities Europe LLP
Charles Street Securities Europe LLP Investment ManagersFinance Charles Street Securities Europe LLP (Charles Street) is a private equity firm founded in 1984. The firm is headquartered in the London, United Kingdom. | Finance |
Vaccine Research International Plc
Vaccine Research International Plc Miscellaneous Commercial ServicesCommercial Services Vaccine Research International Plc is a British company that focuses on conducting clinical trials to evaluate the effectiveness of vaccine SA75 in preventing staphylococcal infections in hospital patients and the wider community. | Commercial Services |
TK-Signal Ltd.
TK-Signal Ltd. Medical SpecialtiesHealth Technology TK-Signal Ltd. develops therapies for hematological cancer applications. Its product TKS040, which manage and trace focused drug therapy for cancer patients. The firm also develops various radiopharmaceutical molecular imaging tracers, specific molecular radiotherapy agents, and radioactive biomarkers to diagnose and monitor cancerous tumors. TK-Signal was founded in 2001 by Eyal Mishani and Alexander Levitzki and is headquartered in Jerusalem, Israel. | Health Technology |
Sepal Pharma Plc
Sepal Pharma Plc Pharmaceuticals: MajorHealth Technology Sepal Pharma Plc is a British company that manufactures pharmaceutical preparations. | Health Technology |
Vidac Pharma Ltd.
Vidac Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vidac Pharma Ltd. manufactures pharmaceutical products. It is a clinical stage biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases. The company was founded in 2011 by Max Herzberg is headquartered in Jerusalem, Israel. | Health Technology |
- Börse
- Insiders
- Gilead Raday
- Erfahrung